Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03546790 · ClinicalTrials.gov registry record · Phase 1
Laboratory Smoking of Marijuana "Blunts"
A Phase 1 study of Cannabis, sponsored by Battelle Memorial Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT03546790: Completed Phase 1 study of Cannabis, sponsored by Battelle Memorial Institute.
NCT03546790 is a Phase 1 study of Cannabis that has completed, run by Battelle Memorial Institute. The registered enrollment target is 8 participants, below the 110-participant average among 24 other Cannabis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03546790, a Phase 1 study of Cannabis, has completed, sponsored by Battelle Memorial Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a double-blind within-subjects clinical laboratory study comparing the product appeal and abuse liability-related subjective effects of different flavored cigar wrappers for marijuana blunts.
Primary Outcome
Total inhalation volume
Conditions Studied
Interventions
- DRUG Marijuana
Study Locations (1)
Maryland
- Battelle Memorial Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-04-10 |
| Est. Completion | 2019-09-30 |
| Phase | Phase 1 |
What the finished NCT03546790 record still lists
NCT03546790 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 110-participant average among 24 other Cannabis trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Cannabis appearing as the primary indexed condition, and to 1 intervention - of which Marijuana is the first listed.
NCT03546790 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03546790 about?
NCT03546790 is a clinical study titled "Laboratory Smoking of Marijuana "Blunts"". This is a double-blind within-subjects clinical laboratory study comparing the product appeal and abuse liability-related subjective effects of different flavored cigar wrappers for marijuana blunts.
What is the current status of trial NCT03546790?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2019-04-10. Estimated completion is 2019-09-30.
What conditions does trial NCT03546790 study?
This clinical trial studies the following conditions: Cannabis.
What interventions are being tested in trial NCT03546790?
The interventions under investigation include: Marijuana (DRUG).
Who is sponsoring clinical trial NCT03546790?
This trial is sponsored by Battelle Memorial Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03546790 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03546790's enrollment target sits among peer trials
8 23rd of 24 higher than 2 of 24 other Cannabis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
RECRUITING · Phase 1
-
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
RECRUITING · Phase 1
-
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I
RECRUITING · Phase 1
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II
ACTIVE NOT RECRUITING · Phase 1
-
Cannabinoids, Learning, and Memory
ACTIVE NOT RECRUITING · Phase 1
-
THC Memory & Reward Learning Pilot
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI